
Specialty
Certifications
Cardiovascular Disease
American Board of Internal Medicine
Clinical Focus
Education
MD, Tulane University
Residency, Internal Medicine
Brigham and Women's HospitalFellowship, Cardiovascular
University of Chicago Hospitals
Biography
Robert S. Rosenson, MD, is Professor of Medicine at the Mount Sinai School of Medicine where he serves as Director of Cardiometabolic Disorders.
Dr. Rosenson earned his medical degree from Tulane University in New Orleans, Louisiana. He then served his residency in medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He later completed a fellowship in cardiology at the University of Chicago that was followed by an additional year of training as a Research Associate in lipoprotein metabolism
Dr. Rosenson has been involved in numerous grant-supported research investigations studying the effects of lipid-lowering therapy, hypoglycemic therapy, and antihypertensive agents in inflammation, thrombogenesis, and rheology. He has served as Principal Investigator on a number of NIH-funded research studies, pharmaceutical-sponsored drug trials, and multicenter studies. Recently, he served as Global Principal Investigator of the PLASMA I, PLASMA II and FRANCIS trials. He has been an invited speaker at more than 200 national and international association meetings, grand rounds, and symposia. He has authored nearly a total of 600 journal articles, book chapters, abstracts, and electronic publications for Up To Date Medicine.
At Mount Sinai Medical Center, he will conduct outpatient sessions that address comprehensive risk factor modification in patients with atherosclerotic vascular disease, primary and secondary prevention of cardiovascular disease in diabetes patients. His particular interest relates to lipoprotein disorders.
Industry Relationships
Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rosenson during 2011 and/or 2012. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- AMARIN; sanofi-aventis
Scientific Advisory Board:
- Abbott Laboratories; Daiichi-Sankyo Co., Ltd.; Genentech, Inc.; LipoScience Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- LipoScience
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Cardiology
One Gustave L. Levy Place
New York, NY 10029

Guggenheim Pavilion
1190 Fifth Ave - 1 West
New York, NY 10029
Fax: 212-659-9033


- Wednesday 1:00pm - 5:00pm
- 1199
- Aetna
- Beech Street
- CIGNA - Indemnity
- CIGNA Healthcare HMO
- Coventry Health Care
- Fidelis/Centercare
- First Health
- GHI HMO
- Group Health Insurance (GHI) - PPO
- HIP Commercial
- Magnacare
- Multiplan/PHCS
- Neighborhood Health Providers, LLC
- Oxford Freedom
- Oxford Liberty
- Pomco
- Master Card
- Visa
- Cash

